Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Human tumors constitutively release endosome-derived microvesicles, transporting a broad array of biologically active molecules with potential modulatory effects on different immune cells. Here, we report the first evidence that tumor-released microvesicles alter myeloid cell function by impairing monocyte differentiation into dendritic cells and promoting the generation of a myeloid immunosuppressive cell subset. CD14+ monocytes isolated from healthy donors and differentiated with interleukin (IL)-4 and granulocyte macrophage colony-stimulating factor in the presence of tumor-derived microvesicles turned into HLA-DR−/low cells, retaining CD14 expression and failing to up-regulate costimulatory molecules, such as CD80 and CD86. These phenotypic changes were paralleled by a significant release of different cytokines, including IL-6, tumor necrosis factor-α, and transforming growth factor-β (TGF-β), and a dose-dependent suppressive activity on activated T-cell–proliferation and cytolytic functions, which could be reversed by anti-TGF-β–neutralizing antibodies. Microvesicles isolated from plasma of advanced melanoma patients, but not from healthy donors, mediated comparable effects on CD14+ monocytes, skewing their differentiation toward CD14+HLA-DR−/low cells with TGF-β–mediated suppressive activity on T-cell–functions. Interestingly, a subset of TGF-β–secreting CD14+HLA-DR− cells mediating suppressive activity on T lymphocytes was found to be significantly expanded in peripheral blood of melanoma patients compared with healthy donors. These data suggest the development in cancer patients of an immunosuppressive circuit by which tumors promote the generation of suppressive myeloid cells through the release of circulating microvesicles and without the need for cell-to-cell contact. Therapeutic interventions on the crucial steps of this pathway may contribute to restore tumor/immune system interactions favoring T-cell–mediated control of tumor growth in cancer patients. (Cancer Res 2006; 66(18): 9290-8)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumor‐derived exosomes are known to inhibit DC differentiation by releasing immunosuppressive factors such as IL‐6 and TGF‐β [94, 95].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling
Taylor, D. D., Akyol, S., & Gercel-Taylor, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1534 · Cited by 297
RetractedThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Indeed, although evidences support a potential role of the immune system in containing tumor development (and thus promoting a more favorable prognosis) in the initial phases of neoplastic disease (27), it is undoubted that, thanks to mechanisms not completely defined, tumors can progressively remodel the host environ…”
BackgroundTumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640 · cited 2×
“Although the possibility to induce effective immunoprotection in tumor-bearing mice vaccinated with tumor-derived exosomes has been reported (37), these results have not been thus far confirmed in human setting, where the clinical application of microvesicles as cancer vaccines has been mainly focused on dendritic cel…”
BackgroundResultTGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355 · cited 2×
“Based on recent report showing TGF-h–mediated impairment of CD8+ lytic functions ( 21 ), we investigated the effect of”
BackgroundExosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343 · cited 2×
“Microvesicle samples from both melanoma patients and healthy donors expressed LAMP-2, a lysosomal-associated membrane protein usually found in microvesicles and exosomes (25), as shown by Western blotting (Fig.”
BackgroundEscudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249 · cited 1×
“Although it would be interesting to analyze the immunomodulatory effects of microvesicles released by melanocytes, representing melanoma nontransformed histologic counterpart, the lack of FasL expression in these normal cells ( 39 ) suggests that production of immunosuppressive microvesicles might be a selective featu…”
BackgroundKawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092 · cited 9×
“doi:10.1158/0008-5472.CAN-06-1819 Cancer Res 2006; 66: ( 18 ).”
BackgroundSelf-citationMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024 · cited 3×
“Nevertheless, several findings support the occurrence of aberrant myeloid differentiation in cancer patients, with defects involving decreased frequencies of mature immunocompetent dendritic cells, accumulation of HLA class II immature dendritic cells and expansion of immature myeloid cells (15).”
BackgroundMalignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953 · cited 2×
“Indeed, since their discovery (35), growing evidence has been collected about the presence of microvesicular organelles in different biological fluids of both cancer patients and healthy individuals (2, 3, 9, 10).”
Background
Cited by
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
“Although exosome release can be demonstrated in many proliferating cell types, their release is exacerbated in tumor cells, as evidenced by their elevated presence in plasma, ascites and pleural effusions of cancer patients [26,27].”
BackgroundRetractedRegulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041152 · Cited by 1,555
Self-citationTetraspanins in Extracellular Vesicle Formation and Function
Andreu, Z., & Yáñez-Mó, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00442 · Cited by 1,487
Metadata
- Authors
- Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L.
- Affiliations
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University of Milano-Bicocca (IT)
- Istituto Superiore di Sanità (IT)
- ORCID
- Venue
- Cancer Research
- Published
- 2006-09-15
- Volume
- 66
- Issue
- 18
- Pages
- 9290-9298
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2142433114
- Cited by
- 493
- References
- 39
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 25 · 2023: 17 · 2022: 30 · 2021: 31 · 2020: 30 · 2019: 27 · 2018: 27 · 2017: 31 · 2016: 35 · 2015: 26 · 2014: 34 · 2013: 32 · 2012: 28
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Funders
- Fondazione Italiana per la Ricerca sul Cancro
- Bracco Imaging
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- myeloid differentiation, dendritic cell differentiation, monocytes, TGF-beta, T cell suppression, immunosuppression, melanoma, HLA-DR, costimulatory molecules, tumor immune evasion, tumor microenvironment
- MeSH terms
- Cell Differentiation, Dendritic Cells, HLA-DR Antigens, Humans, Leukocytes, Mononuclear, Melanoma, Endosomes, T-Lymphocytes, Colorectal Neoplasms, Transforming Growth Factor beta, Apoptosis, Lipopolysaccharide Receptors, Secretory Vesicles, Myeloid Cells, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-1819
- The paper
- Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L. (2006). Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-1819
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.